Understanding early signs of ADHD and autism in infants at risk
An investigation of transdiagnostic mechanisms underlying ASD and ADHD traits among infants at risk
This study is looking at how certain early signs in babies who might be at risk for ADHD and autism can help us understand these conditions better, so we can find ways to spot them early and support families more effectively.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California at Davis NIH-funded |
| Lab location | 1 site (Davis, United States) |
| Project ID | NIH-10834749 on NIH RePORTER |
What this research studies
This research investigates the early developmental mechanisms that may lead to attention-deficit/hyperactivity disorder (ADHD) and autism spectrum disorder (ASD) in infants who are genetically at risk. By examining how factors like attention regulation and emotional responses are linked to these conditions, the study aims to identify potential biomarkers that could help in early detection. The researchers will focus on measuring respiratory sinus arrhythmia, which reflects how well infants can manage their emotions and attention. This approach could provide insights into how symptoms develop over time, potentially leading to better prevention and intervention strategies.
Who could benefit from this research
Good fit: Ideal candidates for this research are infants who are genetically at risk for ADHD and ASD.
Not a fit: Patients who are not at genetic risk for ADHD or ASD may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier detection and intervention for infants at risk of developing ADHD and ASD, improving long-term outcomes.
How similar studies have performed: While this research explores novel mechanisms, previous studies have indicated that early identification of risk factors can lead to improved outcomes in similar populations.
Where this research is happening
Davis, United States
- University of California at Davis — Davis, United States (Active)
Researchers
- Principal investigator: Miller, Meghan Rhys — University of California at Davis
- Study coordinator: Miller, Meghan Rhys
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.